Navigation Links
Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
Date:3/20/2009

WEST PALM BEACH, Fla., March 9 /PRNewswire-FirstCall/ -- Explorations Group Inc. (OTC Bulletin Board: EXGI), announced today that it has signed a non-binding letter of intent to acquire Daniel R. Smith & Associates, Inc. ("DRSA"), a South Florida-based specialty lighting company for a total of $4.2 million to be paid in a combination of cash and debt. In announcing the Letter of Intent, EXGI President David Coriaty stated "the acquisition of DRSA is the next step in EXGI's plan to assemble a one stop solution for security, lighting and access control for the commercial, industrial and governmental markets by extending our product line to include DRSA's marine and industrial lighting solutions. Combined with our February 2009 acquisition of Hawk Biometric Technologies, we are now in position to offer a wide range of products for these markets."

The Boards of Directors of EXGI and DRSA have approved the transaction. EXGI expects to be able to promptly consummate the transaction, subject to due diligence, the execution of definitive agreements, and other conditions to closing. There is no assurance that a definitive agreement providing for the transaction as contemplated by the Letter of Intent will be executed or that the transaction will be consummated.

About EXGI - Explorations Group, Inc. is Florida-based provider of solutions of biometric security, access, lighting and control systems for industrial, commercial and governmental market. EXGI's recently acquired Hawk Biometric Technologies subsidiary is a developer of patented biometric systems for the automotive, real estate and maritime industries. Hawk Biometric's signature PASS(TM) product integrates fingerprint scanning into a vehicle's operating system and permits operation by only authorized drivers. Combined with optional GPS capabilities, PASS(TM) allows vehicle owners to remotely monitor, track, geo-fence, speed check and disable PASS(TM) equipped ve
'/>"/>

SOURCE Explorations Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology news :

1. Explorations Group Acquires Hawk Biometric Technologies, Inc.
2. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
3. Titanium Group Announces Contract With Haitong Securities
4. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
5. Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar
6. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
7. UF botanists: Flowering plants evolved very quickly into 5 groups
8. Tree of life for flowering plants reveals relationships among major groups
9. Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong
10. Group selection, a theory whose time has come...again
11. Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...two different feeding strategies. A large proport... they are generalist predators feeding on other sm... however, are "herbivorous". This is not to say t...r diets consist of plant-derived matter. For examp...s to attract ants, called extra-floral nectar; oth...
(Date:12/1/2009)...s pleased to announce the publication of results f...efficacy and tolerability of its novel, intranasal...chronic rhinosinusitis with nasal polyps in Rhino...nd European Rhinologic Societies. , Chronic rhi... that can significantly reduce a patient,s quality...
(Date:12/1/2009)...disease, nerve cell degeneration plays a crucial r...ssibly be derived from steering the generation and...published in the current issue of the renowned jou... ago, neurogenesis the process of nerve cell deve...ult brain. The textbooks asserted that dead nerve ...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2New source discovered for the generation of nerve cells in the brain 2New Research Shows 3A Neurofeedback is an Evidence Based Treatment for ADHD 4729 1New Research Shows 3A Neurofeedback is an Evidence Based Treatment for ADHD 4729 2Negligible impact on public safety from shark cage diving operations 9272 1Pharmacyclics Announces Subscription Price for Rights Offering 13053 1Pharmacyclics Announces Subscription Price for Rights Offering 13053 2Pharmacyclics Announces Subscription Price for Rights Offering 13053 3
...he projects will together provide to the GBIF netw...8 million species-occurrence data records as well ...rencing service and a workflow for extracting info...vailable in a database format). , As directed in t... address major global issues, including Global Cli...
...il 2008 - FEBS Letters, one of the leading journal...unced today an exciting new enhancement to the jou... , A Structured Digital Abstract in FEBS Letters ...tract comprising of a series of sentences each of ...al entities, mentioning the method used to study t...
... Care Congress is the premier forum for health car...s and to network with key leaders. The 2008 Congre...fficials from the nation,s largest employers, hosp...l and biotech companies, and government. , One of...alth Care Agenda, will feature key health care adv...
Other Biology News:GBIF seed money awards for 2007-2008 2FEBS Letters Structured Digital Abstracts experiment 25th Annual World Health Care Congress April 21-23, Washington, D.C. 2
(Date:12/2/2009)... JERUSALEM, Israel, December 2 ...aluating the preclinical (animal study) safety and... technology from Weill,Cornell Medical College and...eat inherited anemias such as Cooley,s Anemia. ,...nologies to expand, ex vivo,populations of stem/p...
(Date:12/2/2009)...RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ --...any") (OTC Bulletin Board: EMDY), a leading,produc...a, milk powder and,soybean products in China, toda...he Spring issue of US Food & Drink Executive, ...,000 executives in the food and beverage industry....
(Date:12/2/2009)...CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zent..."), a global biopharmaceutical company focused on ...at the U.S. Food and Drug Administration (FDA) has...PI3K/Akt pathway inhibitor compound, perifosine (K... multiple myeloma. Keryx Biopharmaceuticals, Inc. ...
(Date:12/2/2009)... The Scientist, a leading scientific magazin...rsquo; Evolve “Intelligent” EMCCD came... 10 Innovations of 2009. , ...EMCCD camera from Photometrics ®, a designer...D cameras for the life sciences, was ranked fourth...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...1 Cardium Therapeutics (Amex:,CXM) announced that...ct,offering with institutional and other accredite...nced on January 31, 2008. Empire Asset Management,...transaction., (Logo: http://www.newscom.com/cgi-...ere offered pursuant to an effective shelf registr...
...Feb. 1 Amicus Therapeutics,Inc. (Nasdaq: FOLD ),...nd,Chief Executive Officer, will present a corpora...al, Biotechnology & Medical Device Conference in,N... am (Eastern Standard,Time) at the Grand Hyatt Hot...y be accessed by visiting,Amicus, website at http...
...IFF LAKE, N.J., Feb. 1 Eisai Co., Ltd.,(Headquart...i,s U.S.,subsidiary, Eisai Corporation of North Am... Chairman & CEO: Hajime Shimizu), today announced .... Food and Drug,Administration (FDA) of a New Drug...in mesylate) for third-line treatment of advanced ...
Other Biology Technology:Cardium Completes $5.3 Million Registered Direct Offering 2Cardium Completes $5.3 Million Registered Direct Offering 3Cardium Completes $5.3 Million Registered Direct Offering 4Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application 2Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application 3
Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
...y and reliably amplify unknown genomic DNA using ...le-free, ready-to use components, at an extraordin... are provided in each kit. The BAC End Amplificati... large clones such as P1, YAC and BAC, and localiz...
Biology Products: